GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a remarkable development in how we treat diabetes mellitus . These new therapies work by stimulating the body’s own GLP-1 substance , https://bookmark-master.com/story21796451/glp-1-a-major-advance-in-diabetes-treatment